LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
9.29
-0.47 (-4.82%)
At close: Apr 28, 2026, 4:00 PM EDT
9.45
+0.16 (1.72%)
After-hours: Apr 28, 2026, 7:04 PM EDT
LENZ Therapeutics Employees
LENZ Therapeutics had 152 employees as of December 31, 2025. The number of employees increased by 110 or 261.90% compared to the previous year.
Employees
152
Change (1Y)
110
Growth (1Y)
261.90%
Revenue / Employee
$125,579
Profits / Employee
-$540,309
Market Cap
291.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 152 | 110 | 261.90% |
| Dec 31, 2024 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Abeona Therapeutics | 226 |
| AC Immune | 122 |
| Zentalis Pharmaceuticals | 106 |
| C4 Therapeutics | 104 |
| Editas Medicine | 87 |
| Compugen | 75 |
| Cybin | 50 |
LENZ News
- 8 days ago - LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom - GlobeNewsWire
- 5 weeks ago - LENZ Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 weeks ago - LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026 - GlobeNewsWire
- 7 weeks ago - LENZ Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia - GlobeNewsWire
- 2 months ago - LENZ Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - LENZ Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire